Los Angeles clinic used wrong drug for syphilis

	Tweet

Over a period of 5 years, a clinic in Los Angeles used a non-recommended preparation of penicillin to treat nearly 700 syphilis patients and their contacts, according a study released Thursday.

At least one of the patients may have progressed to a more serious form of the disease because of the mix-up.

The incorrect use of the drug was tracked to similarities in proprietary names and packaging of the different preparations, according to an article in the CDC’s Morbidity and Mortality Weekly Report.

The recommended drug, Bicillin L-A, contains 2.4 million units (MU) of benzathine penicillin G. The preparation that was used by mistake, Bicillin C-R, contains a mixture of 1.2 MU benzathine penicillin G and 1.2 MU procaine penicillin, lead author Dr. R. Bolan, of the Los Angeles Gay and Lesbian Center, and associates point out.

Bicillin C-R contains only half the recommended dose of benzathine penicillin G, and levels in the blood are maintained for up to 7 days. In contrast, Bicillin L-A produces effective concentrations for up to 30 days, according to an editorial comment by officials at the Centers for Disease Control and Prevention.

“Prolonged serum concentration is considered essential for treating syphilis effectively,” the CDC editors write.

Between 1999 and 2004, 429 patients with syphilis and 234 of their sexual contacts were incorrectly treated with Bicillin C-R.

Letters, telephone calls, and published press releases were used to reach the patients for re-testing and re-treatment.

Of the original syphilis patients, 282 were successfully contacted and 255 were retreated. One patient who was originally given the wrong drug developed neurosyphilis—that is, infection of the brain and nervous system, which can lead to dementia if untreated.

Among the 234 sexual contacts, 116 were re-contacted. Of these, 22 had serologic evidence of previous syphilis infection and 19 were re-treated.

The investigators are concerned that other facilities may have made the same mistake as the L. A. clinic. “Providers, STD clinics, and pharmacies should review their product records and tracking systems for ordering and delivering penicillin treatments for syphilis," they advise.

As a result of the mix-up, the CDC and the US Food and Drug Administration have worked with the drugs’ manufacturer, King Pharmaceuticals, to change the product labeling and to print warnings on Bicillin C-R syringes and packaging.

SOURCE: Morbidity and Mortality Weekly Report, March 11, 2005.

RELATED STORIES:
Scientists give more evidence of Vioxx heart risks   The Possible Dangers of Buying Medicine Online   Internet tied to rise in drug abuse   Men and Women Differ in Pain Drug Abuse Risks   Bayer forgot to tell risks of heart surgery drug   Drug used worldwide doubles risk of kidney failure   Common antibiotics tied to eye emergencies: study   US warns about risks of Boehringer AIDS drug   Prescription Opioid Abuse, Addiction Less Common Than Many Believe   FDA Urges Lowering Maximum Daily Dose Of Celexa   It Is Easy to Purchase Prescription Drugs and Controlled Substances Through Spam Messages   Opiate painkillers raise fracture risk

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]